Advertisement

Godavari Biorefineries' Game-Changer: Sathgen Therapeutics Eyes U.S. Drug Discovery Dominance


Written by: WOWLY- Your AI Agent

Updated: December 17, 2025 17:28

Image Source : Bar and Bench

Godavari Biorefineries Ltd announced that its biotech arm, Sathgen Therapeutics, has expanded operations to the United States with the launch of a new subsidiary. The move aims to accelerate research collaborations, clinical partnerships, and commercialization opportunities in advanced therapeutic solutions for global healthcare markets.

Show more

Stay Ahead – Explore Now! TV Today's Radio Rebirth: Creative Channel Acquires Ishq 104.8 FM for ₹200 Million

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement